LogicBio Therapeutics
(NASDAQ:LOGC)
$0.5613
0.0666[13.46%]
Last update: 12:23PM
Day High/Low0.49 - 0.58
52 Week High/Low0.34 - 2.54
Open / Close0.5 / -
Float / Outstanding23.4M / 33M
Vol / Avg.162.4K / 1.3M
Mkt Cap18.5M
P/E-
50d Avg. Price0.42
Div / Yield-
Payout Ratio-
EPS-0.28
Total Float23.4M

LogicBio Therapeutics (NASDAQ:LOGC), Quotes and News Summary

LogicBio Therapeutics (NASDAQ: LOGC)

Day High/Low0.49 - 0.58
52 Week High/Low0.34 - 2.54
Open / Close0.5 / -
Float / Outstanding23.4M / 33M
Vol / Avg.162.4K / 1.3M
Mkt Cap18.5M
P/E-
50d Avg. Price0.42
Div / Yield-
Payout Ratio-
EPS-0.28
Total Float23.4M
Sector: Health Care.Industry: Biotechnology
LogicBio Therapeutics Inc is a genome editing company focused on developing medicines to durably treat rare diseases in patients with significant unmet medical need using GeneRide, its proprietary technology platform. Its product candidates include LB-001, LB-101, LB-201 and LB 301.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-19
REV
Q1 2022Est.ActualSurprise
EPS-0.280-0.200 0.0800
REV900.000K2.816M1.916M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

LogicBio Therapeutics Questions & Answers

Q
How do I buy LogicBio Therapeutics (LOGC) stock?
A

You can purchase shares of LogicBio Therapeutics (NASDAQ: LOGC) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are LogicBio Therapeutics's (LOGC) competitors?
Q
What is the target price for LogicBio Therapeutics (LOGC) stock?
A

The latest price target for LogicBio Therapeutics (NASDAQ: LOGC) was reported by Chardan Capital on Tuesday, May 17, 2022. The analyst firm set a price target for 4.00 expecting LOGC to rise to within 12 months (a possible 612.63% upside). 7 analyst firms have reported ratings in the last year.

Q
Current Stock Price for LogicBio Therapeutics (LOGC)?
A

The stock price for LogicBio Therapeutics (NASDAQ: LOGC) is $0.5613 last updated Today at August 8, 2022, 4:23 PM UTC.

Q
Does LogicBio Therapeutics (LOGC) pay a dividend?
A

There are no upcoming dividends for LogicBio Therapeutics.

Q
When is LogicBio Therapeutics (NASDAQ:LOGC) reporting earnings?
A

LogicBio Therapeutics’s Q2 earnings are confirmed for Friday, August 19, 2022.

Q
Is LogicBio Therapeutics (LOGC) going to split?
A

There is no upcoming split for LogicBio Therapeutics.

Q
What sector and industry does LogicBio Therapeutics (LOGC) operate in?
A

LogicBio Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.